awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33400959-054FE5FC-E888-4B83-9302-7E04276245A8
Q33400959-054FE5FC-E888-4B83-9302-7E04276245A8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33400959-054FE5FC-E888-4B83-9302-7E04276245A8
A phase II study of tasisulam sodium (LY573636 sodium) as second-line or third-line treatment for patients with unresectable or metastatic soft tissue sarcoma.
P2860
Q33400959-054FE5FC-E888-4B83-9302-7E04276245A8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33400959-054FE5FC-E888-4B83-9302-7E04276245A8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5eee07fd9b189a057ccc65ebe9cb33b468106213
P2860
Efficacy of sequential high-dose doxorubicin and ifosfamide compared with standard-dose doxorubicin in patients with advanced soft tissue sarcoma: an open-label randomized phase II study of the Spanish group for research on sarcomas.